//fpnotebook.com/
Pyridostigmine
Aka: Pyridostigmine, Pyridostigmine Bromide
- Indications
- Pretreatment before Nerve Agent Exposure (Soman)
- Myasthenia Gravis
- Pharmacokinetics: Nerve Agent Exposure
- Significantly enhances post-exposure antidote for Soman
- Does not enhance antidote for other Nerve Agents
- Raises Soman LD50 by several fold
- Dosing: Nerve Agent Exposure
- Pyridostigmine 30 mg PO every 8 hours before exposure
- Precautions: Nerve Agent Exposure
- Pyridostigmine does not protect against exposure
- Nerve Agent Exposures must be treated with Antidote
- References
- (1998) USAMRICD Chemical Casualties Handbook, p. 58-9